Anson Funds Management’s TransCode Therapeutics RNAZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-52,218
Closed -$724K 134
2025
Q1
$724K Buy
+52,218
New +$724K 0.13% 79